1-5 of 5
Keywords: Hodgkin’s disease
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1996) 19 (2): 114–117.
Published Online: 12 May 2009
...-activating Bi-MAb in patients with refractory Hodgkin’s disease encourage further clinical trials of this novel immunotherapy in patients with malignant tumors refractory to standard treatment. Bispecific antibodies Hodgkin’s disease Malignancies Immunotherapy 12 5 2009 © 1996 S. Karger...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1993) 16 (6): 407–415.
Published Online: 08 May 2009
...H. Tesch; A. Engert; B. Lathan; M. Löffler; D. Hasenclever; M. Pfreundschuh; E. Dühmke; V. Diehl Hodgkin’s disease is curable by radio- and/or chemotherapy. In limited stages most patients are treated with radiotherapy alone, which results in a high cure rate. In intermediate stages a combination...
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1992) 15 (3): 190–196.
Published Online: 29 April 2009
...S. Vijayakumar Hodgkin’s disease is highly curable today. For early stages (stages I, II, and IIIA), radiotherapy is the treatment of choice. Although this treatment has been successful for more than three decades, no definite recommendations can be made as yet regarding the dose requirements...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1989) 12 (2): 99–101.
Published Online: 27 April 2009
...R. Obrist; H.P. Honegger; M. Aapro; K. Bürki; F. Cavalli ABLETOP, a salvage regimen for relapsing Hodgkin’s disease consisting of adriamycin, Weomycín and ewp > osíde, has been evaluated in 18 patients, 16 of whom were evaluable for toxicity and 15 for response. Fourteen patients showed maximal...